Akt3 Antibodies

Santa Cruz Biotechnology provides a broad selection of Akt3 monoclonal antibodies for research focused on understanding cellular processes. Akt3 Antibodies are validated for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Akt3, a member of the Akt family of serine/threonine kinases, plays a crucial role in regulating cell survival, growth, and metabolism. Research has shown that Akt3 significantly impacts cancer development, where alterations in its activity can contribute to tumor progression and resistance to therapy. Understanding Akt3 function continues to be a key focus in developing targeted cancer treatments. Scientists worldwide rely on specific molecular tools to advance their understanding of Akt3's biological significance. Researchers can explore signaling pathways and cellular mechanisms through various experimental approaches. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to scientific knowledge and therapeutic development.